Parents in the United States who want to vaccinate their young children against Covid-19 this fall may face a growing set of ...

As a summer COVID-19 surge hits Michigan, unanswered questions abound about eligibility, insurance coverage and when new ...

Coronavirus infections are climbing again, marking another summer wave as children go back to school. But this uptick arrives ...

Parents won't be able to vaccinate healthy children 6 months to 5 years old if the FDA pulls Pfizer's COVID-19 vaccine authorization.

A third dose of the Pfizer COVID-19 vaccine can "strongly" boost protection against the delta variant, suggests new data released by Pfizer.

There’s some massive news out about COVID-19—and it’s good for a change. Pfizer and BioNTech’s vaccine is reportedly successful in preventing over 90% of infections according to early data ...

Released Tuesday, the AAP's recommendations call for routine vaccination of children ages 6 months to 2 years, citing ...

Pfizer-BioNTech and Moderna have both recently claimed that their COVID vaccines are more than 90 percent effective in preventing the disease.

Pfizer said Wednesday that a final assessment of trial data on the COVID-19 vaccine it developed in conjunction with German company BioNTech showed it was 95% effective, and that it would apply ...

London — U.S. drugmaker Pfizer said Monday that human trials suggest its coronavirus vaccine is 90% effective at preventing COVID-19 infections in people not known to have had the virus already.

A technician inspects vials of coronavirus disease (COVID-19) vaccine candidate BNT162b2 at a Pfizer manufacturing site in manufacturing site in St. Louis, Missouri, U.S. in an undated photograph.

Pfizer (NYSE: PFE) along with its German partner BioNTech, produces one of the most sought-after Covid-19 vaccines and is likely to be a key beneficiary of the renewed focus on vaccine stocks.